0KHE Intrinsic Valuation and Fundamental Analysis - PerkinElmer Inc - Alpha Spread
P

PerkinElmer Inc
LSE:0KHE

Watchlist Manager
PerkinElmer Inc
LSE:0KHE
Watchlist
Price: 116.85 USD -0.71% Market Closed
Market Cap: 1.3T USD
Have any thoughts about
PerkinElmer Inc?
Write Note

Intrinsic Value

The intrinsic value of one 0KHE stock under the Base Case scenario is 1.69 USD. Compared to the current market price of 116.85 USD, PerkinElmer Inc is Overvalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

0KHE Intrinsic Value
1.69 USD
Overvaluation 99%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case
How do you feel about 0KHE?
Bearish
Neutral
Bullish

Valuation Backtest
PerkinElmer Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling 0KHE based on its intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about PerkinElmer Inc

Provide an overview of the primary business activities
of PerkinElmer Inc.

What unique competitive advantages
does PerkinElmer Inc hold over its rivals?

What risks and challenges
does PerkinElmer Inc face in the near future?

Summarize the latest earnings call
of PerkinElmer Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for PerkinElmer Inc.

Provide P/S
for PerkinElmer Inc.

Provide P/E
for PerkinElmer Inc.

Provide P/OCF
for PerkinElmer Inc.

Provide P/FCFE
for PerkinElmer Inc.

Provide P/B
for PerkinElmer Inc.

Provide EV/S
for PerkinElmer Inc.

Provide EV/GP
for PerkinElmer Inc.

Provide EV/EBITDA
for PerkinElmer Inc.

Provide EV/EBIT
for PerkinElmer Inc.

Provide EV/OCF
for PerkinElmer Inc.

Provide EV/FCFF
for PerkinElmer Inc.

Provide EV/IC
for PerkinElmer Inc.

Show me price targets
for PerkinElmer Inc made by professional analysts.

What are the Revenue projections
for PerkinElmer Inc?

How accurate were the past Revenue estimates
for PerkinElmer Inc?

What are the Net Income projections
for PerkinElmer Inc?

How accurate were the past Net Income estimates
for PerkinElmer Inc?

What are the EPS projections
for PerkinElmer Inc?

How accurate were the past EPS estimates
for PerkinElmer Inc?

What are the EBIT projections
for PerkinElmer Inc?

How accurate were the past EBIT estimates
for PerkinElmer Inc?

Compare the revenue forecasts
for PerkinElmer Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of PerkinElmer Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of PerkinElmer Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of PerkinElmer Inc compared to its peers.

Compare the P/E ratios
of PerkinElmer Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing PerkinElmer Inc with its peers.

Analyze the financial leverage
of PerkinElmer Inc compared to its main competitors.

Show all profitability ratios
for PerkinElmer Inc.

Provide ROE
for PerkinElmer Inc.

Provide ROA
for PerkinElmer Inc.

Provide ROIC
for PerkinElmer Inc.

Provide ROCE
for PerkinElmer Inc.

Provide Gross Margin
for PerkinElmer Inc.

Provide Operating Margin
for PerkinElmer Inc.

Provide Net Margin
for PerkinElmer Inc.

Provide FCF Margin
for PerkinElmer Inc.

Show all solvency ratios
for PerkinElmer Inc.

Provide D/E Ratio
for PerkinElmer Inc.

Provide D/A Ratio
for PerkinElmer Inc.

Provide Interest Coverage Ratio
for PerkinElmer Inc.

Provide Altman Z-Score Ratio
for PerkinElmer Inc.

Provide Quick Ratio
for PerkinElmer Inc.

Provide Current Ratio
for PerkinElmer Inc.

Provide Cash Ratio
for PerkinElmer Inc.

What is the historical Revenue growth
over the last 5 years for PerkinElmer Inc?

What is the historical Net Income growth
over the last 5 years for PerkinElmer Inc?

What is the current Free Cash Flow
of PerkinElmer Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for PerkinElmer Inc.

Business Breakdown

PerkinElmer Inc. stands as a prominent player in the field of diagnostics and life sciences, dedicated to improving human and environmental health. Founded over 80 years ago, the company has evolved to meet the demands of an ever-changing market by providing innovative solutions that span a wide range of applications, from prenatal screening to disease detection and environmental monitoring. With a strong commitment to research and development, PerkinElmer has positioned itself at the forefront of science and technology, offering cutting-edge instruments, consumables, and software that empower healthcare providers and researchers alike. The recent strategic acquisitions and partnerships have...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PerkinElmer Inc

Current Assets 3.2B
Cash & Short-Term Investments 2B
Receivables 597.4m
Other Current Assets 607.1m
Non-Current Assets 10.3B
PP&E 646.9m
Intangibles 9.3B
Other Non-Current Assets 296.8m
Current Liabilities 1.4B
Accounts Payable 174.9m
Accrued Liabilities 503.7m
Other Current Liabilities 711.4m
Non-Current Liabilities 4.2B
Long-Term Debt 3.2B
Other Non-Current Liabilities 1B
Efficiency

Earnings Waterfall
PerkinElmer Inc

Revenue
2.7B USD
Cost of Revenue
-1.2B USD
Gross Profit
1.5B USD
Operating Expenses
-1.1B USD
Operating Income
368m USD
Other Expenses
-198.6m USD
Net Income
169.4m USD

Free Cash Flow Analysis
PerkinElmer Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Revvity's Q2 2024 results exceeded expectations despite facing challenges in the pharma and biotech sectors, posting a 1% organic revenue decline, which was on the higher end of projections. Margins rose significantly to 28.7%, leading to an adjusted EPS of $1.22. The company generated $160 million in free cash flow, aided by cost controls and efficiency improvements. Revvity plans to ramp up share repurchases, leveraging its strong cash position and expecting continued robust performance. The company projects a full-year adjusted EPS between $4.70 and $4.80, with expected 2024 revenue ranging from $2.77 billion to $2.79 billion.

What is Earnings Call?
Fundamental Scores

0KHE Profitability Score
Profitability Due Diligence

PerkinElmer Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

50/100
Profitability
Score

PerkinElmer Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

0KHE Solvency Score
Solvency Due Diligence

PerkinElmer Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
70/100
Solvency
Score

PerkinElmer Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

0KHE Price Targets Summary
PerkinElmer Inc

Wall Street analysts forecast 0KHE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0KHE is 139.6 USD with a low forecast of 121.72 USD and a high forecast of 195.08 USD.

Lowest
Price Target
121.72 USD
4% Upside
Average
Price Target
139.6 USD
19% Upside
Highest
Price Target
195.08 USD
67% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for 0KHE?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for 0KHE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about 0KHE dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

0KHE Price
PerkinElmer Inc

1M 1M
-1%
6M 6M
+7%
1Y 1Y
+10%
3Y 3Y
-39%
5Y 5Y
+37%
10Y 10Y
+53%
Annual Price Range
116.85
52w Low
82.05
52w High
124.1313
Price Metrics
Average Annual Return 16.62%
Standard Deviation of Annual Returns 32.69%
Max Drawdown -59%
Shares Statistics
Market Capitalization 1.3T USD
Shares Outstanding 11 025 900 544
Percentage of Shares Shorted
N/A

Competitive Landscape

Profile

PerkinElmer Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

1.3T USD

Dividend Yield

0.24%

Description

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The firm provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. The company offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and others.

Contact

MASSACHUSETTS
Waltham
940 Winter Street
+17816635791.0
www.perkinelmer.com

IPO

1965-07-06

Employees

16 700

Officers

See Also

Discover More
What is the Intrinsic Value of one 0KHE stock?

The intrinsic value of one 0KHE stock under the Base Case scenario is 1.69 USD.

Is 0KHE stock undervalued or overvalued?

Compared to the current market price of 116.85 USD, PerkinElmer Inc is Overvalued by 99%.

Back to Top